Despite these data, the role of PKR as a tumor suppressor is far from clear, with evidence that PKR activation can lead to neoplastic progression in melanoma and colon cancer cells and decreased sensitivity to conventional chemotherapy agents, presumably through up-regulation of pro-survival pathways such as NF-kB [16]. This evidence concerns the gene NFKB1 and colonic neoplasm.